These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1607708)

  • 21. Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strains.
    Kim KS; Cross AS; Kaufmann B; Zollinger W; Sadoff J
    Pediatr Res; 1990 Dec; 28(6):667-70. PubMed ID: 1704500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
    Joiner KA; Warren KA; Tam M; Frank MM
    J Immunol; 1985 May; 134(5):3411-9. PubMed ID: 3920319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bactericidal activity of grass carp Ctenopharyngodon idella C9-deficient serum against Aeromonas hydrophila.
    Ji C; Li AH; Xie J; Zhang DF; Liu JY
    J Fish Biol; 2011 Dec; 79(7):2083-6. PubMed ID: 22141908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bactericidal activity of sera of healthy neonates and of newborns with hyperbilirubinaemia to Escherichia coli.
    Miler I; Vondrácek J; Hromádková L
    Folia Microbiol (Praha); 1979; 24(2):143-52. PubMed ID: 378780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin.
    Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ
    J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111.
    Joiner KA; Fries LF; Schmetz MA; Frank MM
    J Exp Med; 1985 Sep; 162(3):877-89. PubMed ID: 3897448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical quantitation of serum complement components in SFD and AFD infants.
    Ueda H; Nakanishi A; Ichijo M
    Tohoku J Exp Med; 1980 Sep; 132(1):111-6. PubMed ID: 7209963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bactericidal activity of sera of healthy neonates and newborns with hyperbilirubinaemia to E. coli.
    Miler I; Vondrácek J; Hromádková L
    Czech Med; 1979; 2(1-2):29-40. PubMed ID: 393477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.
    Joiner KA; Schmetz MA; Sanders ME; Murray TG; Hammer CH; Dourmashkin R; Frank MM
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4808-12. PubMed ID: 3895225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells.
    Maruvada R; Blom AM; Prasadarao NV
    Immunology; 2008 Jun; 124(2):265-76. PubMed ID: 18028369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sub-minimal inhibitory concentrations of cefmetazole enhance serum bactericidal activity in vitro by amplifying poly-C9 deposition.
    Schweinle JE; Nishiyasu M
    J Clin Invest; 1992 Apr; 89(4):1198-207. PubMed ID: 1556181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement.
    Anderson DC; Hughes BJ; Edwards MS; Buffone GJ; Baker CJ
    Pediatr Res; 1983 Jun; 17(6):496-502. PubMed ID: 6348689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.
    Fierer J; Finley F
    J Clin Invest; 1979 May; 63(5):912-921. PubMed ID: 376551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
    J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.
    Joiner KA; Scales R; Warren KA; Frank MM; Rice PA
    J Clin Invest; 1985 Nov; 76(5):1765-72. PubMed ID: 3932472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K-1 antigen of Escherichia coli: epidemiology and serum sensitivity of pathogenic strains.
    Pitt J
    Infect Immun; 1978 Oct; 22(1):219-24. PubMed ID: 103825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial killing by complement. C9-mediated killing in the absence of C5b-8.
    Dankert JR; Esser AF
    Biochem J; 1987 Jun; 244(2):393-9. PubMed ID: 3311029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The association between deficiency of terminal complement components and the occurrence of meningococcal meningitis].
    Nishizaki M
    Fukuoka Igaku Zasshi; 1992 May; 83(5):201-8. PubMed ID: 1612549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.